1. Pink Sheet
  2. >>Vaccines

Who’s No. 2? After Health Care Workers, A Hot Debate Over Next Group To Get COVID Vaccine

 
• By Derrick Gingery

ACIP officials struggle with whether essential workers or high-risk adults should be next in line when there is a limited vaccine supply.

A selective focus at the end of syringe while needle was injected into deltoid muscle and using the cotton to stop bleeding while pulling the needle out
Modeling showed that vaccinating nursing home personnel would reduce coronavirus infections and deaths more than vaccinating residents. • Source: Shutterstock

Health care workers appear likely to be the first to receive a coronavirus vaccine once it becomes available, but the next group may be much tougher to determine.

Immediately after a vaccine is approved, even though manufacturing already is underway, the number of available doses is expected to be limited, and how to allocate them was a topic at the 26 August meeting of the CDC’s Advisory Committee on Immunization Practices (ACIP)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Vaccines

More from Pink Sheet

Recent and Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.

UK Health Data Research Service Looks ‘Encouraging’ For Industry, But Implementation Details Will Be Key

 
• By Anabel Costa-Ferreira

Marcus Vass and Vladimir Murovec of international law firm Osborne Clarke tell the Pink Sheet what the government's planned HDRS might mean for industry, and how it compares with the European Health Data Space.

EU Health Data Space May Speed Up R&D Through Access To Multi-Omics & Clinical Record Data

 
• By Eliza Slawther

The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.